The Role of Interferon Gamma in Toxic Shock Syndrome
Author Information
Author(s): Tilahun Ashenafi Y., Holz Marah, Wu Tsung-Teh, David Chella S., Rajagopalan Govindarajan
Primary Institution: Mayo Clinic College of Medicine
Hypothesis
Interferon gamma plays a lethal role in the immunopathogenesis of toxic shock syndrome (TSS).
Conclusion
The study identifies that interferon gamma contributes significantly to the lethality associated with toxic shock syndrome by causing fatal small bowel pathology.
Supporting Evidence
- Neutralization of interferon gamma provided significant protection against lethal toxic shock syndrome.
- HLA-DR3.IFN-γ−/− mice showed preserved intestinal architecture and reduced gut permeability during toxic shock syndrome.
- Interferon gamma deficiency did not reduce inflammation in lungs and liver but protected the intestines.
Takeaway
This study found that a substance called interferon gamma can make a serious illness called toxic shock syndrome worse, especially by hurting the intestines.
Methodology
The study used HLA-DR3 transgenic mice to investigate the effects of interferon gamma on toxic shock syndrome induced by staphylococcal enterotoxin B.
Limitations
The study primarily used a mouse model, which may not fully replicate human responses to toxic shock syndrome.
Participant Demographics
HLA-DR3 transgenic mice were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website